BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1468 related articles for article (PubMed ID: 27063583)

  • 1. Omega-3 fatty acids for the treatment of dementia.
    Burckhardt M; Herke M; Wustmann T; Watzke S; Langer G; Fink A
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009002. PubMed ID: 27063583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MGEKN; Tabet N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary interventions for multiple sclerosis-related outcomes.
    Parks NE; Jackson-Tarlton CS; Vacchi L; Merdad R; Johnston BC
    Cochrane Database Syst Rev; 2020 May; 5(5):CD004192. PubMed ID: 32428983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Souvenaid for Alzheimer's disease.
    Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donepezil for dementia due to Alzheimer's disease.
    Birks JS; Harvey RJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega 3 fatty acid for the prevention of cognitive decline and dementia.
    Sydenham E; Dangour AD; Lim WS
    Cochrane Database Syst Rev; 2012 Jun; (6):CD005379. PubMed ID: 22696350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine for dementia.
    McShane R; Westby MJ; Roberts E; Minakaran N; Schneider L; Farrimond LE; Maayan N; Ware J; Debarros J
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD003154. PubMed ID: 30891742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marine-derived n-3 fatty acids therapy for stroke.
    Alvarez Campano CG; Macleod MJ; Aucott L; Thies F
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012815. PubMed ID: 31242320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
    Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marine-derived n-3 fatty acids therapy for stroke.
    Alvarez Campano CG; Macleod MJ; Aucott L; Thies F
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD012815. PubMed ID: 35766825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.
    Parsons C; Lim WY; Loy C; McGuinness B; Passmore P; Ward SA; Hughes C
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD009081. PubMed ID: 35608903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.
    Battle CE; Abdul-Rahim AH; Shenkin SD; Hewitt J; Quinn TJ
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013306. PubMed ID: 33704781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interventions for apathy in Alzheimer's disease.
    Ruthirakuhan MT; Herrmann N; Abraham EH; Chan S; Lanctôt KL
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012197. PubMed ID: 29727467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrolysin for vascular dementia.
    Cui S; Chen N; Yang M; Guo J; Zhou M; Zhu C; He L
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31710397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivastigmine for Alzheimer's disease.
    Birks JS; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
    Downie LE; Ng SM; Lindsley KB; Akpek EK
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal-assisted therapy for dementia.
    Lai NM; Chang SMW; Ng SS; Tan SL; Chaiyakunapruk N; Stanaway F
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31763689
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 74.